+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Ibuprofen"

Cyclo-oxygenase 2 inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Cyclo-oxygenase 2 inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 90 Pages
  • Global
From
From
United States MAXIGESIC IV Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

United States MAXIGESIC IV Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • November 2023
  • 30 Pages
  • United States
From
From
From
From
From
From
Maxigesic IV Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Maxigesic IV Drug Insight and Market Forecast - 2032

  • Report
  • August 2022
  • 30 Pages
  • Global
From
From
From
Research Report on China's Ibuprofen Export 2023-2032 - Product Thumbnail Image

Research Report on China's Ibuprofen Export 2023-2032

  • Report
  • January 2023
  • 50 Pages
  • China
From
Global Ibuprofen API Market 2023-2027 - Product Thumbnail Image

Global Ibuprofen API Market 2023-2027

  • Report
  • March 2023
  • 151 Pages
  • Global
From
Analgesics in Indonesia - Product Thumbnail Image

Analgesics in Indonesia

  • Report
  • September 2023
  • 24 Pages
  • Indonesia
From
Loading Indicator

The Ibuprofen market is a segment of the Over the Counter (OTC) Drugs industry. Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) used to treat pain, fever, and inflammation. It is available in a variety of forms, including tablets, capsules, gels, creams, and liquids. Ibuprofen is one of the most widely used OTC drugs, and is available in both generic and branded forms. It is often used to treat mild to moderate pain, as well as inflammation associated with arthritis and other conditions. Ibuprofen is also used to reduce fever and to treat menstrual cramps. The Ibuprofen market is highly competitive, with a number of major players. Some of the leading companies in the market include Johnson & Johnson, Bayer, Pfizer, GlaxoSmithKline, and Novartis. Show Less Read more